0001104659-11-013322.txt : 20110310 0001104659-11-013322.hdr.sgml : 20110310 20110309173647 ACCESSION NUMBER: 0001104659-11-013322 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110304 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events FILED AS OF DATE: 20110310 DATE AS OF CHANGE: 20110309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CARDIONET INC CENTRAL INDEX KEY: 0001113784 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330604557 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33993 FILM NUMBER: 11676147 BUSINESS ADDRESS: STREET 1: 1010 SECOND AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92101 BUSINESS PHONE: (619) 243-7500 MAIL ADDRESS: STREET 1: 1010 SECOND AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92101 8-K 1 a11-7675_18k.htm 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): March 4, 2011

 

CardioNet, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-33993

 

33-0604557

(State or other jurisdiction

 

(Commission

 

(I.R.S. Employer

of incorporation)

 

File Number)

 

Identification No.)

 

227 Washington Street #300
Conshohocken, PA

 

19428

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (610) 729-7000

 

Not Applicable
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 5.02                                             Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On March 4, 2011, the Board of Directors of CardioNet, Inc. (the “Company”) approved a salary increase for Joseph Capper, President and Chief Executive Officer from $515,000 to $535,000, effective February 28, 2011.

 

On March 4, 2011, the Compensation Committee of the Board of Directors of the Company approved salary increases for certain of its executive officers, effective February 28, 2011, as follows:

 

Name

 

Title

 

Annual Base
Salary After
Increase

 

Heather Getz

 

Senior Vice President, Chief Financial Officer

 

$

298,100

 

Anna McNamara

 

Senior Vice President, Clinical Operations

 

$

321,360

 

George Hrenko

 

Senior Vice President, Human Resources and Organizational Excellence

 

$

263,000

 

Philip Leone

 

Senior Vice President, Reimbursement Services, Regulatory and Compliance

 

$

250,568

 

Charles Gropper

 

Senior Vice President, Research and Development

 

$

225,522

 

 

Item 8.01               Other Events.

 

The Board of Directors has set April 29, 2011, as the date for the Company’s annual meeting of stockholders.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

CardioNet, Inc.

 

 

 

 

 

 

March 9, 2011

By:

/s/ Peter Ferola

 

 

Name: Peter Ferola

 

 

Title: Senior Vice President and General Counsel

 

3